Click here to view this email on your mobile device
View this email in your Web browser: http://whatcounts.jobson.com/dm?id=%%SUBSCRIBER_ID_TAG%%
August 03, 2017
VMail Technology
www.visionmonday.com   Facebook Twitter
In This Edition

SYSTEMS / EQUIPMENT

Eyefficient’s Portable Fundus Camera

EXAMS / DISPENSING

Konan Medical's EvokeDx Gets CE Mark

WEB TECH

MedPhoto Manager Debuts iOS App


SYSTEMS / EQUIPMENT

Eyefficient Intros MediWorks Hand-Held Fundus Camera


More Images
Product: FC160
Top Line: Eyefficient is partnering with MediWorks to introduce their new hand-held Fundus Camera, the FC160, in the U.S. The FC160 joins Eyefficient’s other MediWorks equipment including Digital Slit Lamp Imaging, and LED Vision Chart Systems.
Close Up: “The FC 160 is a sleek, portable non-mydriatic camera with built-in Wi-Fi, Micro SD, and Miracast connectivity,” said Mark Newkirk, CEO of Eyefficient. “It allows quick, easy dissemination of retinal images through the web from remote locations. And features like a 3.97 inch touch screen and five internal fixation targets allow doctors to capture retinal images with ease.”
The camera features a rechargeable lithium-ion battery and weighs only 420 grams.
Vital Stats: The Eyefficient line of products includes brands like MediWorks, Yeasn, S4OPTIK, and others.
www.eyefficient.com

Top Send your comments to VM

EXAMS / DISPENSING

Konan Medical’s EvokeDx Achieves CE Mark, Including Glaucoma Diagnostic Indication


Product: EvokeDx
Top Line: Konan Medical has attained the CE mark for its newest device, EvokeDx. The CE mark is required in Europe by 30 countries in order to market medical devices and is an assurance that the product complies with relevant European health, safety and environment protections. EvokeDx is now approved in Europe for objective assessment of central vision function including the diagnosis of glaucoma.
Close Up: Visual evoked potentials (VEP) are vision-produced, electrophysiological signals recorded near the brain’s visual cortex used to assess visual function and in the case of EvokeDx, include a rapid and objective assessment of magnocellular deficits often associated with glaucoma. Electroretinogram (ERG) signals are recorded in a similar manner but used to assess retina-specific dysfunctions.
icVEP is the patented, isolated-check VEP stimulus and analysis strategy that was the subject of an NIH-sponsored, multi-center clinical trial at five prestigious U.S. sites and two international locations to rapidly and objectively assess glaucomatous damage. “In the NIH-sponsored trials, our icVEP strategy had a classification accuracy of 89 percent to 94 percent for glaucoma,” said Vance Zemon, PhD, a professor at Yeshiva University, Albert Einstein College of Medicine Campus and co-inventor of EvokeDx. “A glaucoma diagnostic indication based upon this data has also been granted for the icVEP strategy in China,” said George Hu, PhD, co-inventor.
Vital Stats: EvokeDx features include patented test strategies that are designed to isolate and objectively test various visual pathways and visual functions, with Fourier-transform frequency analysis methods, and an all-in-one design incorporating a state of the art organic LED stimulus display. Proprietary analysis of the entire EEG waveform provides new information about visual pathway function. EvokeDx is also FDA 510(k) cleared in the U.S. for objective study of central visual function. Low-cost consumables are available from Konan or other suppliers using industry-standard connectors.
www.KonanMedical.com; (949) 521-7730

Top Send your comments to VM

WEB TECH

MedPhoto Manager App Lets Doctors Store and Share Patient Photos


Product: MedPhoto Manager
Top Line: MedPhoto Manager, a health care technology firm, is launching MedPhoto Manager, an iOS application that provides physicians with a secure and reliable tool for taking, storing and sharing patient medical photos. Developed by Michael Samuels, OD, the platform saves physicians time and makes the entire imaging process more efficient. Physicians can thus provide more personalized care for patients, which in turn improves the patient experience and retention, resulting in increased practice revenues.
Close Up: The typical procedure for taking medical photos is time-consuming and cumbersome and can involve nurses and other staff going back and forth from diagnostic machines back to the patient. MedPhoto Manager allows for immediate capture and sharing, directly from a doctor’s mobile device with automatic image storage in a HIPAA-compliant cloud.
Key features:
• A secure database of medical professionals using the application, with the ability for doctors to add “colleagues” for professional communication and networking.
• Ability for doctors to attach informative notes to stored images.
• For patients, medical photo capture and access is covered by health insurance, and the images are billed based on insurance billing code.
• Seamlessly links patients and their associated photos, giving physicians a fast and accurate reference tool to gauge patient progress/prognoses.
Vital Stats: MedPhoto Manager is available as a free download from the iTunes Store. It requires iOS 8.0 or later and is compatible with iPhone, iPad and iPod touch.

Top Send your comments to VM

BACK TO TOP

Send Us Your News & Ideas

Andrew Karp, Group Editor, Lenses and Technology

Send us news about developments in dispensing technology, lens processing equipment, software, diagnostic and web technology. Or provide us with subjects for future stories or topics you'd like to see covered. Contact VMail Technology’s Editor Andrew Karp at akarp@jobson.com.


VMail Technology is a service of Jobson Medical Information LLC, the publisher of VisionMonday®,
440 Ninth Ave, 14th Floor, New York NY 10001.

If you do not wish to receive future VMail Technology e-mails, please click UNSUBSCRIBE.

© 2017 Jobson Medical Information LLC All Rights Reserved EyesWay content is developed, sourced and
reported by the editors of EyesWay, the international news portal. VMail provides that content to its
subscribers as part of an exclusive news exchange agreement.